跳至主要内容
临床试验/DRKS00025155
DRKS00025155已完成不适用

Consequences of the corona restrictions for cancer therapy and survivorship (CroKuS) (COVID-19) - CroKuS

Deutsches Krebsforschungszentrum (DKFZ)0 个研究点目标入组 2,504 人开始时间: 2021年8月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,504

研究概览

简要总结

An average of 21.9% of respondents reported pandemic-related changes in care, with changes in rehabilitation being the most frequently identified area of care. The majority of respondents attributed changes in their rehabilitation to the increased risk of infection, while capacity constraints were more frequently cited as the reason for change for postponed surgeries. Breast cancer patients were most likely to be affected by changes, while prostate cancer patients were least likely. Approximately 50% of those affected by changes in care reported moderate to high distress at the time of the changes; in addition, health-related quality of life differed compared with respondents without treatment changes in terms of daily life limitations due to the disease and symptom severity. Regarding contact limitations, the most frequently reported limitations were restrictions on contacts in public and with relatives, neighbors, and friends (85% and 76%, respectively). Half of those affected by these restrictions said they suffered very much or quite a bit.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • ­- Living in Baden-Württemberg
  • ­- Men and women with 1 of the following primary cancers: Lung cancer [C33-C34], prostate cancer [C61], breast cancer [C50], colorectal cancer [C18-C20], hematooncological disease [C81-C96]
  • - Age at recruitment 18-85 years
  • - Diagnosis: 07/2015-06/2020, 1/3 of those with diagnosis 07/2015-06/2019 and 2/3 with diagnosis 07/2019-06/2020
  • - Not reported to the cancer registry as diseased until 31/12/2020
  • - Able to give informed consent

排除标准

  • ­Disagreement to recording of identity data in the cancer registry of Baden-Württemberg, general disagreement to participate in studies, deceased before receiving the study questionnaire, malign secondary cancer [C00-C97 except C44]

研究者

发起方
Deutsches Krebsforschungszentrum (DKFZ)

相似试验